Denemek ALTIN - Özgür
The New Challenge: Saving Pepsi From Decline
Mint Chennai
|April 04, 2025
After its cola dropped to No. 3, PepsiCo is trying to win back soda drinkers; 'maybe we lost the focus'
The job of rescuing Pepsi-Cola starts very early in the morning for Ram Krishnan. On a recent trip to San Antonio, the head of PepsiCo's U.S. beverage business was up before sunrise for a 5 a.m. meeting with the local sales team, followed by a roundtable discussion at 7 a.m. with managers.
At 8 a.m., they hit the streets. They split into four teams and started visiting stores—Walmart, Dollar General, Circle K, 7-Eleven and four others. They walked through the aisles with scorecards. Are the shelves full? Are the right PepsiCo drinks highlighted? What about the product mix? The shelf tags? The drink cooler at the checkout?
Since taking charge of PepsiCo's all-important U.S. beverage business in February 2024, Krishnan has been trying to fix a big problem. The U.S. market share for Pepsi's classic cola—which once aspired to overtake Coca-Cola's as the nation's favorite soda—had slipped to No. 3, behind Dr Pepper. And some of the company's other drinks, including Gatorade, had been steadily bleeding market share.
"Maybe we lost the focus," Krishnan said in an interview from Texas.
His campaign to claw back customers has kept him on the road almost nonstop, traipsing through stores, Monday through Thursday, week after week, all over the country. "When you're in the situation you're in and want to make some big transformative moves, I think it helps keep the pace and intensity up," he said.
Times are tough for legacy sodas, and they aren't likely to be helped by Health and Human Services Secretary Robert F. Kennedy Jr. referring to sugary, carbonated drinks as "poison." Energy drinks and niche beverages billed as healthier have been grabbing market share for years, and the U.S. soda market now resembles a slowly melting ice cube.
Bu hikaye Mint Chennai dergisinin April 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Chennai'den DAHA FAZLA HİKAYE
Mint Chennai
Small-town wealthy dive into high-risk PMS schemes
Sophisticated, high-risk investments are no longer confined to the rich in metropolitan cities.
1 min
December 04, 2025
Mint Chennai
‘Targeting public debt appropriate during uncertainty’
India’s shift from targeting annual fiscal deficit to long-term debt was appropriate during a period of external economic uncertainty, chief economic adviser V. Anantha Nageswaran said.
1 mins
December 04, 2025
Mint Chennai
Services PMI rebounds in November
India’s services sector rebounded in November, as new business intakes increased amid subdued price pressures and improving demand, a private sw showed on Wednesday.
2 mins
December 04, 2025
Mint Chennai
Climate chaos: Megacities face rapidly rising risks of flooding
Urban spaces in the tropical monsoon belt are the most vulnerable
3 mins
December 04, 2025
Mint Chennai
Seeking affordable financial advice? Try fixed-fee RIAs
Sebi-registered RIAs earn from client fees, not commissions, ensuring conflict-free guidance
5 mins
December 04, 2025
Mint Chennai
IT sector sheds weight in stock market indices as AI rises
Since the start of the year, shares of the five largest firms have seen sharp drops: TCS fell by 23.47%, Infosys 17%, HCLTech 14.74%, Wipro 17.14%, and Tech Mahindra 9.97%.
2 mins
December 04, 2025
Mint Chennai
IT sheds weight in indices as AI rises
Combined weight of IT cos in BSE Sensex down to 18-year low
1 mins
December 04, 2025
Mint Chennai
JLR CEO Balaji's early trials: top exit, cyberattack impact
Gerry McGovern's abrupt removal has created uncertainty over brand and design strategy
3 mins
December 04, 2025
Mint Chennai
IndiGo flights hit by pilot rest rules, weather, leaves
DGCA probing disruption, working with IndiGo to minimize inconvenience
2 mins
December 04, 2025
Mint Chennai
Natco Pharma's cyclical model leaves revenue outlook cloudy
Shares of Natco Pharma Ltd have dropped 38% from the 52-week high of ₹1,505 (December 2024), as the Street grows cautious about its high-risk, high-reward business model.
1 mins
December 04, 2025
Listen
Translate
Change font size
